These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA). Slikker W; Ali SF; Scallet AC; Frith CH; Newport GD; Bailey JR Toxicol Appl Pharmacol; 1988 Jul; 94(3):448-57. PubMed ID: 2456631 [TBL] [Abstract][Full Text] [Related]
3. Neurotoxic effects of the alpha-ethyl homologue of MDMA following subacute administration. Johnson MP; Nichols DE Pharmacol Biochem Behav; 1989 May; 33(1):105-8. PubMed ID: 2476831 [TBL] [Abstract][Full Text] [Related]
4. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds. Colado MI; Green AR Br J Pharmacol; 1994 Jan; 111(1):131-6. PubMed ID: 7516800 [TBL] [Abstract][Full Text] [Related]
5. Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat. O'Loinsigh ED; Boland G; Kelly JP; O'Boyle KM Prog Neuropsychopharmacol Biol Psychiatry; 2001 Apr; 25(3):621-38. PubMed ID: 11371001 [TBL] [Abstract][Full Text] [Related]
6. Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. Commins DL; Vosmer G; Virus RM; Woolverton WL; Schuster CR; Seiden LS J Pharmacol Exp Ther; 1987 Apr; 241(1):338-45. PubMed ID: 2883295 [TBL] [Abstract][Full Text] [Related]
7. Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced neurotoxicity in the rat. Hekmatpanah CR; McKenna DJ; Peroutka SJ Neurosci Lett; 1989 Sep; 104(1-2):178-82. PubMed ID: 2573011 [TBL] [Abstract][Full Text] [Related]
8. MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons. Battaglia G; Yeh SY; De Souza EB Pharmacol Biochem Behav; 1988 Feb; 29(2):269-74. PubMed ID: 2452449 [TBL] [Abstract][Full Text] [Related]
9. Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys. Kleven MS; Woolverton WL; Seiden LS Brain Res; 1989 May; 488(1-2):121-5. PubMed ID: 2472850 [TBL] [Abstract][Full Text] [Related]
11. The acute effect in rats of 3,4-methylenedioxyethamphetamine (MDEA, "eve") on body temperature and long term degeneration of 5-HT neurones in brain: a comparison with MDMA ("ecstasy"). Colado MI; Granados R; O'Shea E; Esteban B; Green AR Pharmacol Toxicol; 1999 Jun; 84(6):261-6. PubMed ID: 10401727 [TBL] [Abstract][Full Text] [Related]
12. Long-term central 5-HT depletions resulting from repeated administration of MDMA enhances the effects of single administration of MDMA on schedule-controlled behavior of rats. Li AA; Marek GJ; Vosmer G; Seiden LS Pharmacol Biochem Behav; 1989 Jul; 33(3):641-8. PubMed ID: 2573905 [TBL] [Abstract][Full Text] [Related]
13. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. Battaglia G; Yeh SY; O'Hearn E; Molliver ME; Kuhar MJ; De Souza EB J Pharmacol Exp Ther; 1987 Sep; 242(3):911-6. PubMed ID: 2443644 [TBL] [Abstract][Full Text] [Related]
14. Enantiomeric differences in the effects of 3,4-methylenedioxymethamphetamine on extracellular monoamines and metabolites in the striatum of freely-moving rats: an in vivo microdialysis study. Hiramatsu M; Cho AK Neuropharmacology; 1990 Mar; 29(3):269-75. PubMed ID: 1691459 [TBL] [Abstract][Full Text] [Related]
15. Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity. Johnson M; Stone DM; Bush LG; Hanson GR; Gibb JW Eur J Pharmacol; 1989 Feb; 161(2-3):181-8. PubMed ID: 2470597 [TBL] [Abstract][Full Text] [Related]
16. (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats. Mokler DJ; Robinson SE; Rosecrans JA Eur J Pharmacol; 1987 Jun; 138(2):265-8. PubMed ID: 2887440 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the neurotoxicity of N-methyl-1-(4-methoxyphenyl)-2-aminopropane (para-methoxymethamphetamine, PMMA). Steele TD; Katz JL; Ricaurte GA Brain Res; 1992 Sep; 589(2):349-52. PubMed ID: 1382813 [TBL] [Abstract][Full Text] [Related]
18. 3,4-Methylenedioxyethylamphetamine (MDE), a novel analogue of MDMA, produces long-lasting depletion of serotonin in the rat brain. Ricaurte GA; Finnegan KF; Nichols DE; DeLanney LE; Irwin I; Langston JW Eur J Pharmacol; 1987 Jun; 137(2-3):265-8. PubMed ID: 2886355 [TBL] [Abstract][Full Text] [Related]
19. Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate. Gough B; Ali SF; Slikker W; Holson RR Pharmacol Biochem Behav; 1991 Jul; 39(3):619-23. PubMed ID: 1723797 [TBL] [Abstract][Full Text] [Related]
20. Neurochemical basis of neurotoxicity. Gibb JW; Johnson M; Hanson GR Neurotoxicology; 1990; 11(2):317-21. PubMed ID: 1978271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]